Reilly Financial Advisors’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Reilly Financial Advisors’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-500	Closed	-$22K	–	1488
2015 Q3	$22K	Hold	500	–	–	﹤0.01%	583
2015 Q2	$21K	Hold	500	–	–	﹤0.01%	673
2015 Q1	$19K	Buy	+500	New	+$19.3K	﹤0.01%	684

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Reilly Financial Advisors's WX Position: Q4 2015 in Review

Reilly Financial Advisors sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 500 shares — an estimated $22K sold.

Reilly Financial Advisors first reported a position in WX in Q1 2015 and held it in 3 quarters. The position peaked at $22K in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Reilly Financial Advisors reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Reilly Financial Advisors sold 500 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $22K.
Reilly Financial Advisors first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2015 and held it in 3 quarters.
Reilly Financial Advisors's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $22K in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Reilly Financial Advisors's 13F filing for Q4 2015, filed 22 Jan 2016.